Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer CenterRoland B. Walter, Elihu H. Estey, Bob Löwenberg et al.|Leukemia|2014Cited by 172
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyB. Gerber, Guido Ghilardi, Thomas Pabst et al.|Bone Marrow Transplantation|2018Cited by 20